For questions about financial assistance,
call 1-844-DUPIXENT, option 1 or
click to learn more
DUPIXENT is an FDA-approved treatment for patients
with chronic spontaneous urticaria (CSU) ages 2 years and up
who continue to have hives that are not controlled with H1
antihistamine treatment.
FIRST AND ONLY
FDA-APPROVED
BIOLOGIC
IN PATIENTS
AS YOUNG as
DUPIXENT helps reduce itching
and the number of hives that
make CSU so disruptive.
DUPIXENT targets an underlying
source of inflammation inside
your body.
DUPIXENT works continuously
between doses to help you get
ahead of your symptoms.
You’re not alone. For many, hives show up unannounced without any apparent trigger. CSU is not
an allergic reaction.
The Chronic Spontaneous Urticaria (CSU) Skin Gallery highlights photos from real CSU patients to help you understand what it may look like across various skin tones.
*This platform provides access to dermatology specialists only.
Sanofi US and Regeneron do not endorse or recommend any particular physician, and search results do not include a comprehensive list of doctors in your area.
Sign up to get exclusive access to helpful resources and information about:
All fields are required.
Eligible patients with commercial health insurance may pay as little as $0*
in copay per fill of DUPIXENT. Terms and conditions apply.
*THIS IS NOT INSURANCE. Not valid for prescriptions paid, in whole or in part, by Medicaid, Medicare, VA, DOD, TRICARE, or other federal or state programs, including any state pharmaceutical assistance programs. Subject to the program maximum per patient per calendar year. DUPIXENT MyWay reserves the right to rescind, revoke, terminate, or amend this offer, eligibility, and terms of use at any time without notice. Additional terms and conditions apply.